These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36855072)

  • 1. Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry.
    Baichan P; Naicker P; Augustine TN; Smith M; Candy G; Devar J; Nweke EE
    Clin Proteomics; 2023 Mar; 20(1):8. PubMed ID: 36855072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Long Noncoding RNAs Expression Profiles Between Gallstone and Gallbladder Cancer Using Next-Generation Sequencing Analysis.
    Wang Q; Bi P; Luo D; Cao P; Chen W; Yang B
    Int J Gen Med; 2024; 17():2417-2431. PubMed ID: 38813241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma.
    Wang J; Jin Y; Li S; Song Q; Tang P
    J Int Med Res; 2020 May; 48(5):300060520918061. PubMed ID: 32406793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach.
    Rawal N; Hariprasad G; Bandyopadhyay S; Ranjan Dash N; Kumar S; Das P; Dey S; Ahmad Khan M; Ranjan A; Chopra A; Saluja S; Hussain S; Rath GK; Kaur T; Tanwar P
    Biomol Biomed; 2024 Sep; ():. PubMed ID: 39284282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
    Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer.
    Priya R; Jain V; Akhtar J; Saklani N; Sakhuja P; Agarwal AK; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
    Front Oncol; 2022; 12():1027914. PubMed ID: 36505879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma.
    Su L; Zhang J; Zhang X; Zheng L; Zhu Z
    Med Oncol; 2021 Oct; 38(12):141. PubMed ID: 34655361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
    Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
    Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue proteome analysis for profiling proteins associated with lymph node metastasis in gallbladder cancer.
    Jain V; Akhtar J; Priya R; Sakhuja P; Goyal S; Agarwal AK; Ghose V; Polisetty RV; Sirdeshmukh R; Siraj F; Gautam P
    BMC Cancer; 2023 May; 23(1):402. PubMed ID: 37142981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer.
    Akhtar J; Jain V; Kansal R; Priya R; Sakhuja P; Goyal S; Agarwal AK; Ghose V; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
    Front Oncol; 2022; 12():1046974. PubMed ID: 36686780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
    Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
    Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer.
    Zuo M; Rashid A; Wang Y; Jain A; Li D; Behari A; Kapoor VK; Koay EJ; Chang P; Vauthey JN; Li Y; Espinoza JA; Roa JC; Javle M
    Oncotarget; 2016 Jun; 7(23):35302-12. PubMed ID: 27167107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting gallbladder cancer: a pathway based perspective.
    Baichan P; Naicker P; Devar JWS; Smith M; Candy GP; Nweke E
    Mol Biol Rep; 2020 Mar; 47(3):2361-2369. PubMed ID: 32020429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.
    Akhtar J; Priya R; Jain V; Sakhuja P; Agarwal AK; Goyal S; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
    BMC Cancer; 2020 Dec; 20(1):1175. PubMed ID: 33261560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    Nweke EE; Naicker P; Aron S; Stoychev S; Devar J; Tabb DL; Omoshoro-Jones J; Smith M; Candy G
    PLoS One; 2020; 15(10):e0240453. PubMed ID: 33048956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
    Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
    Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility.
    Pandey SN; Dixit M; Choudhuri G; Mittal B
    Int J Gastrointest Cancer; 2006; 37(4):124-8. PubMed ID: 17987404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.